About Hatchtech
Single application head lice product capable of killing both eggs and lice.
Investors
Hatchtech is a venture backed private company backed by some of the largest and most influential life sciences investors in Australia:
- GBS Venture Partners
- Queensland Biotechnology Funds
- Uniseed
- University of Melbourne Endowment Trust
- AustralianSuper
- OneVentures Innovation Fund
Latest News
Mar 12, 2013 Hatchtech appoints Hugh Alsop as CEO
Dec 13, 2012 Hatchtech completes financing round and commences Phase 3 program
Nov 28, 2012 Hatchtech Mechanism of Action Data and Safety Study Published
Sep 05, 2012 Successful FDA End-of-Phase 2 for Hatchtech Head Lice Product DeOVO™